RT @RichardPAConway: Comparative risks of skin SCC and BCC with different DMARDs. Abatacept appeared worst, HR 2.18, but
Tweet Content
Comparative risks of skin SCC and BCC with different DMARDs. Abatacept appeared worst, HR 2.18, but may be residual confounding due to burden disease/comorbidities. Abstr#1942 #ACR21 @RheumNow https://t.co/UzOwuKKFmX
Show on Archive Page
On
Display in Search Results
On
PDQ
Off